ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
MR Scanning of Very Young Children With Severe Developmental Disorders

This study has been completed.

Sponsors and Collaborators: UMC Utrecht
Netherlands Organisation for Scientific Research
De Hersenstichting (The Dutch Brain Foundation)
Information provided by: UMC Utrecht
ClinicalTrials.gov Identifier: NCT00156221
  Purpose

The specific is to study the MR morphologic and spectroscopic brain correlates and predictors of development in children with severe developmental disorders (autistic spectrum disorders and/or mental retardation and/or language disorders). Given the frequently observed association of autism with known medical conditions, particularly in cases with comorbid mental retardation and in cases with atypical autism (Rutter et al., 1994; Gillberg, 1995), children with suspected autism or related developmental disorders will be asked to participate in an extensive state of the art laboratory work-up which includes T1 and T2 weighted MRI of the brain. MRI data will be analyzed both qualitatively, looking for focal abnormalities and degree of myelination, and quantitatively, measuring volumes of total brain, cerebellum, ventricles and grey and white matter. For research purposes, the work-up will be supplied with proton Magnetic Resonance Spectroscopy (MRS) of the brain. This data set provides the opportunity to chart brain-behavior relationships in young children with suspected autism and related PDD cross-sectionally.


Condition
Autism
Mental Retardation
Language Disorder

MedlinePlus related topics:   Autism    Developmental Disabilities    Nuclear Scans   

U.S. FDA Resources

Study Type:   Observational
Study Design:   Natural History, Cross-Sectional, Convenience Sample, Retrospective/Prospective Study
Official Title:   MR Scanning of Very Young Children With Severe Developmental Disorders (Autistic Spectrum Disorders and/or Mental Retardation and/or Language Disorders)

Further study details as provided by UMC Utrecht:

Study Start Date:   September 2000
Estimated Study Completion Date:   September 2005

  Eligibility
Ages Eligible for Study:   18 Months to 7 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

  • Age 18 months to 7 years
  • Diagnosis of autism spectrum disorder, a language disorder or mental retardation

Exclusion Criteria:

  • Significant motor or sensory impairment
  • Major physical abnormalities
  • History of serious head injury
  • Identifiable neurologic disorder
  • Metal implants
  • Contraindication for MRI
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00156221

Locations
Netherlands
UMC Utrecht    
      Utrecht, Netherlands, 3508 GA

Sponsors and Collaborators
UMC Utrecht
Netherlands Organisation for Scientific Research
De Hersenstichting (The Dutch Brain Foundation)

Investigators
Study Chair:     Herman van Engeland, PhD, MD     UMC Utrecht    
Principal Investigator:     Mijke Zeegers, Msc     UMC Utrecht    
  More Information


Study ID Numbers:   METC UMC Utrecht 99/184
First Received:   September 8, 2005
Last Updated:   September 8, 2005
ClinicalTrials.gov Identifier:   NCT00156221
Health Authority:   Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)

Keywords provided by UMC Utrecht:
Autism  
MRI  
Developmental Disorders  

Study placed in the following topic categories:
Child Development Disorders, Pervasive
Developmental Disabilities
Mental Retardation
Signs and Symptoms
Mental Disorders
Autistic Disorder
Mental Disorders Diagnosed in Childhood
Neurologic Manifestations
Language Disorders
Neurobehavioral Manifestations
Communication Disorders

Additional relevant MeSH terms:
Pathologic Processes
Disease
Nervous System Diseases

ClinicalTrials.gov processed this record on October 10, 2008




Links to all studies - primarily for crawlers